• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AESCULAP AG AS FEMUR EXTENS.STEM 6 D12X77 CEMENTED; KNEE ENDOPROSTHETICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AESCULAP AG AS FEMUR EXTENS.STEM 6 D12X77 CEMENTED; KNEE ENDOPROSTHETICS Back to Search Results
Model Number NR291Z
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Pain (1994)
Event Type  Injury  
Manufacturer Narrative
Manufacturing site evaluation: investigation on-going.Additional information / investigation results will be provided in a supplemental report.
 
Event Description
It was reported that there was an issue with as femur extens.Stem 6° d12x77 cemented.The pre-operative diagnosis in 2017 was status post primary knee replacement with multi-directional instability.The patient was initially implanted with enduro components on (b)(6) 2017.Treatment included stimulan pellets with 240mg of tobramycin and 500 mg of vancomycin per mixture; and components were comented one-on-one with tobramycin.There was a failed right total knee with hinge, revision due to loosening and black wear debris seen in synovium on (b)(6) 2020.The patient had been having increased knee pain throughout the day and night; arthrofibrosis was noted.A revision surgery was necessary.The implant that was revised was the aesculap enduro femur.Tranexamic acid had been given during the procedure.All components were cemented one-on-one with tobramycin, followed by stimulan pellets and tobramycin and vancomycin mixture.Additional information was requested.The adverse event is filed under xc (b)(4).
 
Manufacturer Narrative
General information: the product is not available for an investigation.Consequences for the patient post-operative medical intervention was necessary: revision surgery.Investigation: no product at hand, therefore an investigation at the devices is not possible.Conclusion and root cause: based on the information available it is not possible to determine a definitive root cause for the failure at that time.Rationale: there are many potential sources regarding to implant loosening: modification/ change in the surgical technique; cement technique; patient fall; patient allergy/infection.Product safety case was created.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AS FEMUR EXTENS.STEM 6 D12X77 CEMENTED
Type of Device
KNEE ENDOPROSTHETICS
Manufacturer (Section D)
AESCULAP AG
po box 40
tuttlingen, 78501
GM  78501
MDR Report Key9958907
MDR Text Key187791680
Report Number9610612-2020-00102
Device Sequence Number1
Product Code KRO
Combination Product (y/n)N
PMA/PMN Number
K101815
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 06/30/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberNR291Z
Device Catalogue NumberNR291Z
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/19/2020
Initial Date FDA Received04/14/2020
Supplement Dates Manufacturer Received06/10/2020
Supplement Dates FDA Received07/01/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-